The CTN 334: Sex Now/Test Now 2022 team is hitting the streets at Pride festivals across Canada to…
Ahead of World Cancer Day, we spoke with Dr. Troy Grennan about anal cancer screening among gbMSM living…
In recognition of Bell Let’s Talk Day, we look at what steps can be taken to improve mental…

Dr. Jordan Sang joined the CTN in 2021 as a postdoctoral fellow. He is no stranger to the…
CTN 300: The Engage Study is investigating the use of PrEP among urban Canadian gay, bisexual, and other…
New funding for CTN 300-2 will allow the study team to document COVID-19 infection, immunity, and related determinants…
Our Resource Library is a place to share documents, videos, and training resources about HIV and STBBI research and related topics.
There are no results message
The CTN+ supports clinical trials, implementation science projects, and non-interventional research of the highest scientific and ethical standards.
A multicenter, randomized controlled trial of the efficacy, safety and immunogenicity of the 9-valent human papillomavirus (HPV) vaccination in preventing recurrence of high-grade anal dysplasia in HIV-positive men who have sex with men (MSM)
Our researchers and trainees have produced hundreds of peer-reviewed publications in a wide range of HIV- and STBBI-related areas.